Combulin™

Combulin™

Primary Indication Treatment of Type 2 diabetes mellitus
Stage of Development Preclinical
  • As a follow-on product to Capsulin, Diabetology is developing an oral combination therapy bringing insulin and an oral antidiabetic agent together
  • Therapeutic benefit from simultaneous dosing of insulin and insulin sensitizer
Print Print | Sitemap
© 2017, Diabetology Ltd